U.S. flag

An official website of the United States government

Display Settings:

Items per page

PMC Full-Text Search Results

Items: 9

1.
Fig. 2

Fig. 2. From: Use of chitosan bandage to prevent fatal infections developing from highly contaminated wounds in mice.

Photographs of representative mice with HemCon or alginate bandages.

Marina Burkatovskaya, et al. Biomaterials. ;27(22):4157-4164.
2.
Fig. 3

Fig. 3. From: Use of chitosan bandage to prevent fatal infections developing from highly contaminated wounds in mice.

Comparison of adhesion times of HemCon and alginate bandages to infected mouse wounds.

Marina Burkatovskaya, et al. Biomaterials. ;27(22):4157-4164.
3.
Fig. 8

Fig. 8. From: Use of chitosan bandage to prevent fatal infections developing from highly contaminated wounds in mice.

Survival curves of mice with P. aeruginosa infection treated with HemCon (n = 8), alginate (n = 6), AgSD (n = 20), or no treatment (n = 8).

Marina Burkatovskaya, et al. Biomaterials. ;27(22):4157-4164.
4.
Fig. 6

Fig. 6. From: Use of chitosan bandage to prevent fatal infections developing from highly contaminated wounds in mice.

Survival curves of mice with P. mirabilis infection treated with HemCon (n = 8), alginate (n = 12), AgSD (n = 10), or no treatment (n = 10).

Marina Burkatovskaya, et al. Biomaterials. ;27(22):4157-4164.
5.
Fig. 9

Fig. 9. From: Use of chitosan bandage to prevent fatal infections developing from highly contaminated wounds in mice.

Mean bioluminescence values (bars = SEM) of cyclophosphamide-treated mice with S. aureus infection treated with HemCon, alginate, or no treatment. ***, P < 0.001; **, P < 0.01 vs. all other treatments.

Marina Burkatovskaya, et al. Biomaterials. ;27(22):4157-4164.
6.
Fig. 5

Fig. 5. From: Use of chitosan bandage to prevent fatal infections developing from highly contaminated wounds in mice.

Mean bioluminescence values (bars = SEM) of mice with P. mirabilis infection treated with HemCon, alginate, AgSD, or no treatment. ***P < 0.001; **P < 0.01 vs. all other treatments.

Marina Burkatovskaya, et al. Biomaterials. ;27(22):4157-4164.
7.
Fig. 4

Fig. 4. From: Use of chitosan bandage to prevent fatal infections developing from highly contaminated wounds in mice.

Representative bioluminescence images at same bit range of mice with P. mirabilis-infected wounds with treated HemCon (A–D), alginate (E–H), or no treatment control (J–L). Panel (M) shows overnight incubation of blood sample from moribund mouse demonstrating bioluminescent bacteremia.

Marina Burkatovskaya, et al. Biomaterials. ;27(22):4157-4164.
8.
Fig. 7

Fig. 7. From: Use of chitosan bandage to prevent fatal infections developing from highly contaminated wounds in mice.

Mean bioluminescence values (bars = SEM) of mice with P. aeruginosa infection treated with HemCon, alginate, AgSD, or no treatment. ***, P < 0.001 vs. no treatment and alginate. HemCon was only significantly different from AgSD (P < 0.01) at 24 and 36 h.

Marina Burkatovskaya, et al. Biomaterials. ;27(22):4157-4164.
9.
Fig. 1

Fig. 1. From: Use of chitosan bandage to prevent fatal infections developing from highly contaminated wounds in mice.

In vitro antimicrobial effects of dissolved HemCon bandage. Bacteria (108/mL) were incubated with a 1% aqueous solution of HemCon bandage (pH = 4.5) or with a control acetate buffer (pH = 4.5) and aliquots withdrawn at the indicated times for determination of CFU. Points are means of three independent determinations and bars are SEM.

Marina Burkatovskaya, et al. Biomaterials. ;27(22):4157-4164.

Display Settings:

Items per page

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center